Viewing Study NCT06612151


Ignite Creation Date: 2025-12-24 @ 11:44 PM
Ignite Modification Date: 2025-12-25 @ 9:37 PM
Study NCT ID: NCT06612151
Status: RECRUITING
Last Update Posted: 2025-02-11
First Post: 2024-09-23
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Phase III Study of YL201 in Relapsed Small Cell Lung Cancer
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module